204 related articles for article (PubMed ID: 31968646)
1. Chitooligosaccharides Modulate Glucose-Lipid Metabolism by Suppressing SMYD3 Pathways and Regulating Gut Microflora.
Wang Q; Jiang Y; Luo X; Wang C; Wang N; He H; Zhang T; Chen L
Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31968646
[TBL] [Abstract][Full Text] [Related]
2. Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice.
Zheng J; Yuan X; Cheng G; Jiao S; Feng C; Zhao X; Yin H; Du Y; Liu H
Carbohydr Polym; 2018 Jun; 190():77-86. PubMed ID: 29628262
[TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic and hypolipidemic activities of Grifola frondosa polysaccharides and their relationships with the modulation of intestinal microflora in diabetic mice induced by high-fat diet and streptozotocin.
Guo WL; Deng JC; Pan YY; Xu JX; Hong JL; Shi FF; Liu GL; Qian M; Bai WD; Zhang W; Liu B; Zhang YY; Luo PJ; Ni L; Rao PF; Lv XC
Int J Biol Macromol; 2020 Jun; 153():1231-1240. PubMed ID: 31759027
[TBL] [Abstract][Full Text] [Related]
4. Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ).
Bai Y; Zheng J; Yuan X; Jiao S; Feng C; Du Y; Liu H; Zheng L
Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30463189
[TBL] [Abstract][Full Text] [Related]
5. Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice.
Xie X; Xiao Q; Xiong Z; Yu C; Zhou J; Fu Z
Food Funct; 2019 Oct; 10(10):6779-6791. PubMed ID: 31576875
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
7. Oral Exposure of Mice to Carbendazim Induces Hepatic Lipid Metabolism Disorder and Gut Microbiota Dysbiosis.
Jin Y; Zeng Z; Wu Y; Zhang S; Fu Z
Toxicol Sci; 2015 Sep; 147(1):116-26. PubMed ID: 26071454
[TBL] [Abstract][Full Text] [Related]
8. Modulation by geraniol of gene expression involved in lipid metabolism leading to a reduction of serum-cholesterol and triglyceride levels.
Galle M; Kladniew BR; Castro MA; Villegas SM; Lacunza E; Polo M; de Bravo MG; Crespo R
Phytomedicine; 2015 Jul; 22(7-8):696-704. PubMed ID: 26141755
[TBL] [Abstract][Full Text] [Related]
9. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice.
Yan F; Li N; Shi J; Li H; Yue Y; Jiao W; Wang N; Song Y; Huo G; Li B
Food Funct; 2019 Sep; 10(9):5804-5815. PubMed ID: 31461095
[TBL] [Abstract][Full Text] [Related]
10. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.
Xu L; Li Y; Yin L; Qi Y; Sun H; Sun P; Xu M; Tang Z; Peng J
Theranostics; 2018; 8(20):5593-5609. PubMed ID: 30555566
[TBL] [Abstract][Full Text] [Related]
11. Hypolipidemic activity of okra is mediated through inhibition of lipogenesis and upregulation of cholesterol degradation.
Wang H; Chen G; Ren D; Yang ST
Phytother Res; 2014 Feb; 28(2):268-73. PubMed ID: 23606408
[TBL] [Abstract][Full Text] [Related]
12. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
Yang X; Zhang J; Chen L; Wu Q; Yu C
Exp Cell Res; 2018 May; 366(2):152-160. PubMed ID: 29548750
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of chitooligosaccharides for the management of diabetes in alloxan induced mice: a correlative study with antihyperlipidemic and antioxidative activity.
Katiyar D; Singh B; Lall AM; Haldar C
Eur J Pharm Sci; 2011 Nov; 44(4):534-43. PubMed ID: 21964204
[TBL] [Abstract][Full Text] [Related]
14. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats.
Li L; Guo WL; Zhang W; Xu JX; Qian M; Bai WD; Zhang YY; Rao PF; Ni L; Lv XC
Food Funct; 2019 May; 10(5):2560-2572. PubMed ID: 30994668
[TBL] [Abstract][Full Text] [Related]
15. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.
Kübeck R; Bonet-Ripoll C; Hoffmann C; Walker A; Müller VM; Schüppel VL; Lagkouvardos I; Scholz B; Engel KH; Daniel H; Schmitt-Kopplin P; Haller D; Clavel T; Klingenspor M
Mol Metab; 2016 Dec; 5(12):1162-1174. PubMed ID: 27900259
[TBL] [Abstract][Full Text] [Related]
16. Chitosan oligosaccharides attenuate loperamide-induced constipation through regulation of gut microbiota in mice.
Zhang X; Yang H; Zheng J; Jiang N; Sun G; Bao X; Lin A; Liu H
Carbohydr Polym; 2021 Feb; 253():117218. PubMed ID: 33278982
[TBL] [Abstract][Full Text] [Related]
17. Odd-numbered agaro-oligosaccharides alleviate type 2 diabetes mellitus and related colonic microbiota dysbiosis in mice.
Wang X; Yang Z; Xu X; Jiang H; Cai C; Yu G
Carbohydr Polym; 2020 Jul; 240():116261. PubMed ID: 32475553
[TBL] [Abstract][Full Text] [Related]
18. Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice.
Qian M; Lyu Q; Liu Y; Hu H; Wang S; Pan C; Duan X; Gao Y; Qi LW; Liu W; Wang L
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31269758
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effect of Chitooligosaccharide Tablets on Lipids in High-Fat Diets Induced Hyperlipidemic Rats.
Yang D; Hu C; Deng X; Bai Y; Cao H; Guo J; Su Z
Molecules; 2019 Jan; 24(3):. PubMed ID: 30709014
[TBL] [Abstract][Full Text] [Related]
20. Mulberry extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance.
Ou TT; Hsu MJ; Chan KC; Huang CN; Ho HH; Wang CJ
J Sci Food Agric; 2011 Dec; 91(15):2740-8. PubMed ID: 22002411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
